The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Antengene presents ATG-109 preclinical data at SITC 2026

Nov 9, 2026 00:30 (15h ago)

Verifying

Antengene presented AnTenGager-D2 and ATG-109 data at the 2026 SITC Annual Meeting.
ATG-109 showed a half-life of approximately 183.5 hours in human FcRn mice.
The study was selected among SITC 2026’s TOP150 abstracts, with presentation poster #896.